Tablets of Avigan are displayed during a photo opportunity at Fujifilm’s headquarters in Tokyo


Tablets of Avigan (generic name : Favipiravir), a drug approved as an anti-influenza drug in Japan and developed by drug maker Toyama Chemical Co, a subsidiary of Fujifilm Holdings Co. are displayed during a photo opportunity at Fujifilm’s headquarters in Tokyo October 22, 2014. REUTERS/Issei Kato


+ Nu sunt comentarii

Adauga comentariu